Executive Medical Director, Early Clinical Aesthetics

Eli Lilly and Company; South San Francisco (CA); On-site; USD 320,000 - 420,000; Full time

Job summary

Scorpion Therapeutics seeks an Executive Medical Director, Early Clinical Development in Aesthetic Medicine to lead translational efforts from discovery to early clinical testing. You will oversee trial design, biomarker integration, and cross-functional collaboration across discovery, clinical, and regulatory teams.

The role emphasizes external scientific engagement, regulatory strategy, and portfolio shape, with a focus on aesthetic dermatology and regenerative approaches.

Qualifications

• MD/DO with board eligibility/certification in Dermatology, Plastic Surgery, or related
• 5+ years industry experience in early clinical development, with experience in aesthetic indications, biomarker development, and clinical trial design
• Track record in translational medicine, regulatory strategy, and external scientific engagement

Responsibilities

• Develop and refine therapeutic hypotheses for skin, facial, and body aesthetics
• design and oversee early clinical trials integrating translational endpoints and biomarkers
• collaborate across functions (discovery, clinical, regulatory)
• evaluate external opportunities
• influence portfolio strategy
• establish external scientific relationships
• support regulatory interactions
• mentor teams
• operate as a culture-shaping leader

Job description

Scorpion Therapeutics seeks an Executive Medical Director, Early Clinical Development in Aesthetic Medicine to lead translational efforts from discovery to early clinical testing. You will oversee trial design, biomarker integration, and cross-functional collaboration across discovery, clinical, and regulatory teams.

The role emphasizes external scientific engagement, regulatory strategy, and portfolio shape, with a focus on aesthetic dermatology and regenerative approaches.